ask="1.98"
ask_size="2700"
average_daily_volume="1876700"
bid="1.94"
bid_size="500"
book_value="1.37"
change="+0.36"
change_from_200_day_moving_average="-3.32"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-6.26"
change_From_52_week_low="0.76"
change_in_percent="+22.50%"
close="1.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.34"
ebitda="-82.29M"
eps_estimate_current_year="-0.21"
eps_estimate_next_quarter="-0.09"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="69786000"
high="1.96"
high_52_weeks="8.22"
last_trade_date="1/6/2017"
last_trade_price="1.96"
last_trade_size="98537"
last_trade_time="4:00pm"
low="1.59"
low_52_weeks="1.20"
market_capitalization="145.38M"
moving_average_200_day="5.28"
moving_average_50_day="2.08"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="1.60"
pe_ratio="N/A"
peg_ratio="-1.04"
percent_change_from_200_day_moving_average="-62.88%"
percent_change_from_50_day_moving_average="-5.67%"
percent_change_from_52_week_high="-76.16%"
percent_change_from_52_week_low="+63.33%"
previous_close="1.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.17"
price_per_sales="749.54"
revenue="158333.00"
shares_outstanding="74173000"
short_ratio="3.34"
stock_exchange="NMS"
symbol="ARWR"
volume="4057195"
weeks_range_52="1.20 - 8.22"
